Blum Robert I's Form 4 filing
Cytokinetics Inc (CYTK) · filed Aug 11, 2023
- Accession no.
- 0001127602-23-022368
- Filed
- Aug 11, 2023
- Trade date
- Dec 21, 2022-Aug 11, 2023
- Filing delay
- 233 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $843.8K. It was filed 233 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blum Robert ICIK 0001288859 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $9.65 | +$96,500 | 416,412 | Direct | |
| Dec 21, 2022 | Common Stock | SSaleDisposed | −10,000 | $43.92 | −$439,200 | 406,412 | Direct | |
| Aug 11, 2023 | Common Stock | MOption exerciseAcquired | +11,708 | $9.65 | +$112,982.2 | 453,125 | Direct | |
| Aug 11, 2023 | Common Stock | SSaleDisposed | −11,708 | $32.37 | −$378,987.96 | 441,417 | Direct | |
| Aug 11, 2023 | Common Stock | MOption exerciseAcquired | +792 | $7.96 | +$6,304.32 | 442,209 | Direct | |
| Aug 11, 2023 | Common Stock | SSaleDisposed | −792 | $32.37 | −$25,637.04 | 441,417 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2022 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 155,691 | Direct | |
| Aug 11, 2023 | Common Stock | MOption exerciseDisposed | −11,708 | $0.00 | $0 | 0 | Direct | |
| Aug 11, 2023 | Common Stock | MOption exerciseDisposed | −792 | $0.00 | $0 | 10,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.